Novo Nordisk H1 Profit Up - Quick Facts

(RTTNews) - Insulin maker Novo Nordisk A/S (NVO) reported a rise in first-half 2014 net profit to 13.45 billion kroner, or 5.09 kroner per share, from last year's 12.72 billion kroner, or 4.69 kroner per share. Quarterly operating profit increased by 12% in local currencies and by 4% in Danish kroner to 16.8 billion kroner.

During the first half of 2014, sales increased by 7% in local currencies driven by Levemir and Victoza and was up 1% in Danish kroner to 42.0 billion kroner, compared with the same period in 2013.

Looking ahead, 2014 sales growth measured in local currencies is still projected to be 7-10% and operating profit growth measured in local currencies is still expected at around 10%.